Cigna now offers employers $200 Wegovy, Zepbound copay option The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

For patients, the monthly copay for GLP-1 weight loss medications will be capped at $200 or less, offering a more affordable option than cash payment programs. Additionally, these copayments will ...

Hospital indemnity insurance is a plan that pays you directly when you're in the hospital. You can use it together with your main health insurance policy to lower your out-of-pocket expenses, such as ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Cigna's Evernorth caps GLP-1 weight-loss drug costs at $200/month, saving patients up to $3,600/year.

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit insured customers’ monthly out-of-pocket expenses for weight-loss drugs ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...